Back to search
Thromboangiitis Obliterans (Buerger's Disease)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Thromboangiitis Obliterans (Buerger's Disease) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Thromboangiitis Obliterans (Buerger's Disease) trials you may qualify forThis study is a first-in-human clinical trial of drug ATI-1013, in healthy adult cigarette smokers. The main questions it aims to answer are to learn about the…
The goal of this observational, practice-based feasibility study is to observe the efficacy and safety of intramuscular administration of Stempeucel® in Malaysi…
The purpose of this expanded access program (EAP) is to provide Selexipag (Uptravi) for the treatment of participant with non-healing wound, buerger's disease.
The goal of this observational study is to learn about the long-term effects of Donaperminogene Seltoplasmid Injection (NL003) in participants who have been rec…
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Telomere Length in Peripheral Blood Leukocytes A Follow-up Pilot Study The goa…